Answer in one sentence: AI belongs in a deal model only after the claimed benefit is reconciled to workflow-level costs, ownership, access controls, remediation needs and the timing of integration.

What this report owns

This report translates the Enterprise AI Buying and Budget Index into transaction diligence, a data-room request list and a benefit bridge. It does not estimate valuation, market size or causal impact, and it does not present operator responses as private equity sentiment.

Key October evidence

Evidence sources: See the CFO AI Leverage Report for funding and payback, the CISO AI Leverage Report for security funding, the AI Leaders AI Leverage Report for production evidence and Executive AI Statistics for complete distributions and provenance.

What October changes for deal teams

The October refresh adds production evidence to a diligence problem that is often framed only as opportunity. Forty-six percent of AI Leaders respondents describe their function as deployed in production and another 13 percent as embedded (base 91), while separate production, cost and access questions show that production status does not itself establish complete operating evidence. The results do not mean the same companies lack controls, and they do not establish transaction risk for a particular target. They mean production status cannot close the diligence question by itself.

The finance instrument also separates three economic conditions that a management presentation may collapse: net-new funding, reallocation from existing spend and money that would otherwise have gone to headcount. Because the question is multi-select, those routes can coexist. A deal team should therefore ask how each claimed benefit is treated in the model rather than assuming that “AI savings” means cash removed from the run rate.

No private equity survey was fielded. This report applies separate operator instruments to transaction questions, with every base shown. Its conclusions concern evidence design, not private equity sentiment, valuation multiples or the prevalence of problems across targets.

Six-question AI deal screen

Use this screen before building a detailed upside or remediation case. A “yes” should point to a record that can be reviewed, not solely to an interview answer.

ScreenPass conditionIf the answer is incomplete
1. What is actually in production?Material workflows are distinguished from pilots, demos and approved-but-unused toolsExclude unverified deployments from the operating case and request a production inventory
2. Who owns the operating result?Sponsor, business owner, technical owner and control owner are namedCreate a decision-rights exception and identify the post-close owner
3. Is the benefit reproducible?Baseline, result, period, source system and evidence owner reconcileHold the claim outside verified deal benefits until it can be reproduced
4. Is full run cost visible?Model, infrastructure, tools, integration, human review and controls are includedBuild a cost range and sensitivity rather than assume the vendor bill is complete
5. Can actions and data access be reconstructed?Identity, privileges, logs, review and revocation apply to the deployed systemPrice and sequence attribution, access or logging remediation
6. Will the claim survive the transaction?Contracts, data, systems, owners and dependencies have a viable target stateTreat disruption, migration and remeasurement as integration work

The screen is intentionally binary only at the first pass. A partial answer should become a named diligence exception with an owner, evidence request and decision effect. It should not be averaged into a generic technology-risk rating.

The transaction diligence matrix

Diligence questionOctober evidenceBaseWhat to verify
Who can authorize AI?CEO 49%; finance 31%; no single owner 13%467Sponsor, operating owner and approval record
Where does the money come from?41% net-new; 31% no clear budget; 19% headcount-linked389Recurring run cost, displaced spend and benefit category
What blocks scale?54% name proving ROI389Baseline, measurement window and decision threshold
Is production cost visible?44% full; 39% partial; 17% none77Workflow-level cost and gross-margin sensitivity
How do agents access data?37% shared accounts among applicable answers49Attribution, privilege, logging and revocation
Is security funding explicit?68% name agent access as a problem; 34% name a dedicated budget line151Control roadmap and funded remediation

The 34-point security comparison does not measure budget adequacy. Respondents could also report case-by-case funding or an existing security-budget carve-out, and the question was multi-select.

Private equity AI data-room request list

Request these records for every material production workflow and for any AI claim included in the investment case:

  1. The production inventory, including workflow, launch date, model or vendor and current operating status.
  2. The decision-rights record naming the executive sponsor, business owner, technical owner and control owner.
  3. The last twelve months of model, infrastructure, tooling, integration, review and control costs by workflow where available.
  4. The benefit file showing the pre-AI baseline, measurement window, result, source system and person accountable for the claim.
  5. The identity and access map, including shared credentials, approved data scope, action permissions, logs and revocation procedures.
  6. Material vendor contracts, data-processing terms, service commitments, model-change terms and termination assistance.
  7. The incident, override and exception log, plus open remediation items, owners, expected cost and target dates.
  8. The integration dependency map covering data, systems, models, people and contracts that would change under the value-creation plan.

This list is a practical diligence asset, not a statement that every respondent maintains these records.

EBITDA and benefit bridge

Do not move an AI claim directly from a management presentation into adjusted EBITDA. Reconcile the claim through a bridge that separates cash, capacity, revenue and recurring delivery cost.

Bridge lineEvidence requiredTreatment question
Claimed gross benefitWorkflow baseline, current result and measurement periodIs the change measured against a stable baseline?
Cash payroll savingPayroll record and removed position or spendDid cash cost actually leave the run rate?
Avoided hiringApproved plan, unfilled role and capacity evidenceIs this avoided future spend rather than a current-period saving?
Redeployed capacityHours released and documented new outputDid capacity create a measurable result elsewhere?
Revenue or gross-profit contributionUsage, conversion, price, retention and delivery-cost evidenceIs the result incremental and repeatable?
AI run costModel, infrastructure, tools and support by workflowDoes cost increase with usage or complexity?
Control and remediation costSecurity, legal, audit, data and monitoring workIs the required control spend included in the case?
Net verified benefitReconciled benefit less recurring and required costsWhich portion is sufficiently evidenced for the deal model?

Money that would otherwise have gone to headcount appears in 19 percent of finance-instrument answers (base 389, any mention). That response can describe cash savings, avoided hiring or redeployed capacity, which are not interchangeable. Separately, 13 percent of AI Leaders respondents describe AI as embedded enough that removing it would alter the cost structure or hiring plan (base 91). Neither figure establishes an EBITDA adjustment without company-level evidence.

Cost visibility and maturity

Full cost visibility rises with maturity: 61 percent among deployed respondents versus 22 percent among those still exploring, matched base 75
GroupBaseFull visibilityPartial visibilityNo visibility
Exploring1822%33%44%
Piloting1436%43%21%
Deployed in production3361%33%6%
Embedded (removing it would change our cost structure or hiring plan)1050%50%0%

Matched respondents answering both questions; base 75. Small row bases are directional.

Full cost visibility is 22 percent among explorers and 61 percent among respondents with production deployments. Even in the production row, 39 percent report only partial or no real-time visibility. The sample is selective and the row bases are small, so this cut should shape diligence questions, not valuation assumptions.

The matched table shows a cross-sectional association, not a sequence or causal effect. Full visibility is more frequently reported in the deployed row than in the exploring row, but the survey does not establish how or when respondents moved between stages. Embedded status does not guarantee full visibility: five of ten embedded respondents report partial rather than full visibility. Because the embedded row contains only ten respondents, this observation is directional. It supports a diligence question (whether the target can trace cost at the workflow level), not an estimate of how mature companies generally perform.

Cost visibility also needs a declared boundary. “Full” may refer to model and infrastructure spend while omitting integration support, human review, observability, security, legal or data work. The target should state what is metered directly, what is allocated, what is estimated and what is excluded. A deal team can then run the same bridge under a base case, an upside case and a control-complete case.

Applying the evidence by deal type

Control buyout

In a control transaction, the investor can make ownership, reporting and remediation part of the operating model. The diligence output should therefore be specific enough to seed the first 100-day plan. Priorities include a material-workflow inventory, the benefit-and-cost bridge, an identity and access remediation queue, vendor and data dependencies, and the executive who will approve continue, change or stop decisions.

The key distinction is between underwriting evidence and future opportunity. A claim supported by a reproducible baseline and full cost can enter the verified case, subject to normal forecasting risk. A plausible but unmeasured workflow belongs in the value-creation pipeline. A system with unresolved attribution, contractual or data issues may require a funded remediation case before expansion. Keeping these lanes separate prevents upside from funding its own proof.

Growth or late-stage minority investment

In a minority investment, governance rights and information access may be narrower. The investor may not control the target's architecture, procurement or remediation sequence. The useful diligence output is therefore a concise covenant or information-rights schedule: which AI measures management will report, which material changes require notice, which incidents or exceptions escalate, and which evidence the board or investor can inspect.

For an AI product company, revenue and delivery-cost evidence may deserve priority. For an AI-enabled operating company, workflow benefits, avoided hiring and process dependencies may matter more. In both cases, the investor should avoid importing a control-deal remediation plan that it lacks the rights to implement. Instead, define reporting thresholds, decision forums and the evidence required before additional capital supports scale.

Add-on acquisition and integration

An add-on creates a different risk: the target's AI workflows may depend on a tenant, data environment, model contract or identity system that will change. A technically successful deployment can lose its evidence trail during integration. Preserve the pre-close inventory, logs, baseline and cost record; name the target-state owner; and decide whether each workflow continues, migrates, pauses or retires. Recalculate the benefit after the relevant systems and costs change.

Reading the October evidence in a deal model

The common sign-off finding (CEO named in 49 percent of answers) suggests senior approval is common in this selective sample. It does not show who owns delivery after approval. The 13 percent “no single owner” line is similarly not proof of weak governance; distributed authority may be deliberate. Diligence should establish whether the design is explicit and whether escalation works.

The finance finding that 54 percent name proving ROI as a blocker indicates that evidence of value is a central operating constraint in that instrument. It does not show that 54 percent of deals have unprovable returns. For a transaction, the practical response is to reproduce the target's largest claims and document the decision threshold used when a result falls short.

The 36-point difference between production-agent presence and full cost visibility compares separate questions with bases of 75 and 77. It is not a respondent-level gap and should never be presented as “36 percent of companies have agents without cost visibility.” The matched maturity table offers a narrower respondent-level view, with small and directional rows.

Finally, shared accounts among 37 percent of applicable responses identify an attribution question, not a finding of noncompliance. A shared account may sit behind strong workload-level logs and narrow privileges, or it may not. The target's actual implementation determines remediation need and cost.

Remediation and integration questions

Remediation before close

Integration after close

These questions turn a generic technology workstream into priced, owned and testable deal actions.

Failure modes that distort AI diligence

Each failure mode has the same remedy: return to the deployed workflow, state the evidence boundary and record how the answer affects underwriting, a condition to close, the 100-day plan or ongoing monitoring.

Stakeholder responsibilities

StakeholderPrimary decisionEvidence it should own or challenge
Deal partnerWhether an AI claim changes price, structure or investment caseVerified/open/excluded claim schedule
Operating partnerWhich opportunities and gaps enter the value-creation planWorkflow roadmap, owners, milestones and decision gates
Finance diligenceHow benefit and cost enter the modelEBITDA and benefit bridge, cost boundary and sensitivities
Technology and security diligenceWhether production dependencies and controls are understoodInventory, architecture, identities, logs, incidents and remediation
Legal diligenceWhether contracts and data rights support the target stateVendor/customer terms, notices, change rights and evidence duties
ManagementWhether each material workflow continues, changes or stopsReproducible operating and outcome record

Comparison with external research

External sourceRelevant contextDeal-team application
McKinsey on generative AI in private marketsAI-generated diligence can diverge from expert evidence on market size, pricing and marginsReconcile every material portfolio-company claim to workflow, cost, identity and measured outcome

This external research is context, not part of the Open Future Forum sample and not evidence about a particular target.

Questions this report answers

What belongs in a private equity AI data room?

Include the production inventory, decision rights, workflow cost ledger, benefit file, identity and access map, material contracts, incident and exception log, remediation plan and integration dependency map.

How should an AI benefit enter an EBITDA bridge?

Separate realized cash savings, avoided hiring, redeployed capacity, revenue or gross-profit contribution, recurring AI run cost and required remediation. Only the net amount supported by company-level evidence should inform the deal model.

Which AI issues can create post-close remediation or integration cost?

Shared credentials, incomplete logs, unclear ownership, weak cost allocation, vendor dependencies and data or system changes can all require funded work. The October data shows shared service accounts in 37 percent of applicable AI Leaders responses (base 49), but that operator statistic does not establish the condition of a specific target.

What are the six questions in an initial AI deal screen?

Ask what is in production, who owns the result, whether the benefit is reproducible, whether full run cost is visible, whether actions and data access can be reconstructed, and whether the claim will survive the transaction.

Should the same AI diligence plan be used for control and minority investments?

No. A control investor can place remediation and operating-model changes directly into the value-creation plan. A minority investor should align evidence requests with governance rights, information rights and escalation thresholds it can actually exercise.

Does production deployment prove an AI claim belongs in the deal model?

No. Production establishes operating status. The claim still needs a stable baseline, measured result, full cost, responsible owner and a test of whether it remains valid after integration.

How should a deal team treat an AI claim with missing evidence?

Classify it as an open hypothesis, state the missing record and run the model without assuming the benefit. Move it into the verified case only when the evidence can be reproduced.

Key citable facts

Methodology and limitations

This is a synthesis of operator data, not a survey of private equity professionals. It does not estimate market size, company valuation, EBITDA impact or causal effect. Bases from separate instruments are reported independently. Respondents are deduplicated by email for each question, invited-only rows are excluded, and multi-select questions use any mention. The data-room list, benefit bridge and deal questions are recommended diligence tools, not survey findings.

Citation

Suggested citation: Newlands, M. (2026). Private Equity AI Report, October 2026. Open Future Forum.

Work These Questions with Dealmaking Peers

Forum Select meets through small, off-the-record gatherings. Membership is by application and referral.

Explore Forum Select Inquire about membership